Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
ClinicalTrials.gov study NCT04624633. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
ClinicalTrials.gov study NCT03336333. IPD Sharing: YES. Countries: 15. Publications: 9.
Analysis of DNA methylation profile of Korean chronic lymphocytic leukaemia (CLL) patients with MeDIP-Seq
<p>In this study, we performed genome-wide methylation profiling of eight CLL patients and five control subjects, in an Asian cohort. Methyl-CpG-binding domain sequencing (MBD-Seq) was used as the profiling method. Differential methylation analysis identified a number of differentially methylated regions (DMRs) and genes (DMGs). More regions were hypomethylated than were hypermethylated. Promoters contained the highest proportion of DMRs, while distal intergenic and intron regions contained the largest number of DMRs. Gene Ontology, pathway analysis, and network-based prioritization of DMGs were also performed.</p>
Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512)
ClinicalTrials.gov study NCT01539291. IPD Sharing: YES. Countries: 5. Publications: 1.
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
ClinicalTrials.gov study NCT01659255. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor The
ClinicalTrials.gov study NCT02141282. IPD Sharing: YES. Countries: 1. Publications: 3.
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
ClinicalTrials.gov study NCT00090051. IPD Sharing: Not stated. Countries: 17. Publications: 2.
A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lym
ClinicalTrials.gov study NCT02264574. IPD Sharing: YES. Countries: 16. Publications: 6.
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
ClinicalTrials.gov study NCT01569295. IPD Sharing: YES. Countries: 18. Publications: 2.
Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
ClinicalTrials.gov study NCT01722487. IPD Sharing: NO. Countries: 16. Publications: 9.
A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON)
ClinicalTrials.gov study NCT01300247. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
ClinicalTrials.gov study NCT00974233. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02983617. IPD Sharing: NO. Countries: 1. Publications: 0.
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
ClinicalTrials.gov study NCT03702231. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02756611. IPD Sharing: YES. Countries: 21. Publications: 1.
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
ClinicalTrials.gov study NCT01414205. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00802737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
ClinicalTrials.gov study NCT02717611. IPD Sharing: YES. Countries: 6. Publications: 2.
TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04163718. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01191190. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.